Up a level |
Alomran, Nessrin, Blundell, Patricia, Alsolaiss, Jaffer, Crittenden, Edouard, Ainsworth, Stuart, Dawson, Charlotte A, Edge, Rebecca J, Hall, Steven R ORCID: 0000-0001-5314-4970, Harrison, Robert A, Wilkinson, Mark C et al (show 2 more authors)
(2022)
Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
TOXINS, 14 (7).
443-.
Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Clare, Rachel H, Xie, Chunfang, Westhorpe, Adam, Hall, Steven R ORCID: 0000-0001-5314-4970, Edge, Rebecca J, Alsolaiss, Jaffer, Crittenden, Edouard, Marriott, Amy E, Harrison, Robert A et al (show 2 more authors)
(2022)
In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus.
Toxicon: X, 14.
p. 100118.
Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Litschka-Koen, Thea, Edge, Rebecca J, Alsolaiss, Jaffer, Crittenden, Edouard, Hall, Steven R, Westhorpe, Adam, Thomas, Brent, Murray, James, Shongwe, Nondusimo et al (show 5 more authors)
(2022)
Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing.
PLOS NEGLECTED TROPICAL DISEASES, 16 (9).
e0010496-.